Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,838 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.
Suzuki F, Arase Y, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kobayashi M, Matsuda M, Takagi K, Satoh J, Kumada H. Suzuki F, et al. Among authors: suzuki y. J Viral Hepat. 2004 May;11(3):271-6. doi: 10.1111/j.1365-2893.2004.00509.x. J Viral Hepat. 2004. PMID: 15117331
Efficacy and changes of the nonstructural 5A GENE by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA.
Arase Y, Ikeda K, Chayama K, Murashima N, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Kobayashi M, Kumada H. Arase Y, et al. Among authors: suzuki y. Intern Med. 1999 Jun;38(6):461-6. doi: 10.2169/internalmedicine.38.461. Intern Med. 1999. PMID: 10411349 Free article. Clinical Trial.
Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy.
Arase Y, Ikeda K, Chayama K, Murashima N, Tsubota A, Nakamura I, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Kobayashi M, Kumada H. Arase Y, et al. Among authors: suzuki y. J Gastroenterol. 1999 Oct;34(5):594-9. doi: 10.1007/s005350050378. J Gastroenterol. 1999. PMID: 10535487 Clinical Trial.
Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer.
Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Chayama K, Murashima N, Kumada H. Ikeda K, et al. Among authors: suzuki f, suzuki y. Hepatology. 2000 Aug;32(2):228-32. doi: 10.1053/jhep.2000.9409. Hepatology. 2000. PMID: 10915728 Clinical Trial.
Relationship between five-year histological outcome and serial changes in serum alanine aminotransferase in patients with biochemical and virological relapse after interferon treatment for chronic hepatitis C.
Kobayashi M, Ikeda K, Akuta N, Someya T, Suzuki F, Tsubota A, Suzuki Y, Saitoh S, Arase Y, Chayama K, Kumada H. Kobayashi M, et al. Among authors: suzuki f, suzuki y. Intervirology. 2000;43(3):174-9. doi: 10.1159/000025043. Intervirology. 2000. PMID: 11044811 Clinical Trial.
16,838 results
You have reached the last available page of results. Please see the User Guide for more information.